Clindamycin Completed Phase 4 Trials for Acne Vulgaris / Post Inflammatory Hyperpigmentation Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00807014Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
NCT02058628Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris
NCT01231334A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
NCT00219570Dalacin-T Gel Post Approval Study
NCT00757523Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
NCT01047189Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
NCT03402893The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
NCT00160394Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
NCT00671749Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
NCT00926367Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT01015638Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
NCT00964366Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
NCT00964223A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne